0000899243-22-013466.txt : 20220404 0000899243-22-013466.hdr.sgml : 20220404 20220404184831 ACCESSION NUMBER: 0000899243-22-013466 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220401 FILED AS OF DATE: 20220404 DATE AS OF CHANGE: 20220404 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Korn Jerald CENTRAL INDEX KEY: 0001782282 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35945 FILM NUMBER: 22804534 MAIL ADDRESS: STREET 1: 128 GORDON RD CITY: NEWTON STATE: MA ZIP: 02468 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Epizyme, Inc. CENTRAL INDEX KEY: 0001571498 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261349956 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 TECHNOLOGY SQUARE STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-229-5872 MAIL ADDRESS: STREET 1: 400 TECHNOLOGY SQUARE STREET 2: 4TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-04-01 0 0001571498 Epizyme, Inc. EPZM 0001782282 Korn Jerald C/O EPIZYME, INC. 400 TECHNOLOGY SQUARE, 4TH FLOOR CAMBRIDGE MA 02139 0 1 0 0 Chief Operating Officer Stock Option (Right to Buy) 1.14 2022-04-01 4 A 0 800000 0.00 A 2032-03-31 Common Stock 800000 800000 D This equity award was not granted pursuant to any pre-existing equity incentive plan of Epizyme, Inc. (the "Company"), but rather was granted as an inducement material to the Reporting Person entering into employment with the Company in accordance with Nasdaq Stock Market Listing Rule 5635(c)(4). This option was granted on April 1, 2022 with respect to 800,000 shares of Common Stock of the Company, with 25% vesting on April 1, 2023 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter. /s/ John Weidenbruch, attorney-in-fact 2022-04-04